
Worldpanel estimates users’ households spent £1bn less on groceries than expected, as snack purchases weakened and frozen meals gained.
Households with a GLP-1 weight-loss drug user in Great Britain spent an estimated £1bn less on groceries than expected, according to research by Worldpanel by Numerator. The figure compares their spending in the year after treatment began with that of similar households.
The estimate reflects a change in shopping behaviour, not a reported £1bn fall in supermarkets’ total sales. Worldpanel’s research, based on more than 9,600 households, also found that users’ households bought 415 million fewer food items.
The shift varied by product. Alcohol and crisp spending fell about 15% more in households with a GLP-1 user than in other households, while sales of frozen ready-meals rose 30%.
Use of the drugs is growing. In August, 8.5% of Great Britain households had at least one GLP-1 user, up from 6.3% in February. About 2.6 million adults were taking the medication, roughly 700,000 more than in February.
Worldpanel said pills accounted for 11.2% of GLP-1 users in August. The research firm estimates that households with a user could exceed 10% of Great Britain households in 2027.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.